Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mary C. Zanarini, Ed.D.

Co-Author

This page shows the publications co-authored by Mary Zanarini and Frances Frankenburg.
Connection Strength

15.290
  1. Frankenburg FR, Fitzmaurice GM, Zanarini MC. The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. J Clin Psychiatry. 2014 Apr; 75(4):357-61.
    View in: PubMed
    Score: 0.645
  2. Frankenburg FR, Zanarini MC. Relationship between cumulative BMI and symptomatic, psychosocial, and medical outcomes in patients with borderline personality disorder. J Pers Disord. 2011 Aug; 25(4):421-31.
    View in: PubMed
    Score: 0.536
  3. Zanarini MC, Weingeroff JL, Frankenburg FR. Defense mechanisms associated with borderline personality disorder. J Pers Disord. 2009 Apr; 23(2):113-21.
    View in: PubMed
    Score: 0.456
  4. Zanarini MC, Frankenburg FR. A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. J Pers Disord. 2008 Jun; 22(3):284-90.
    View in: PubMed
    Score: 0.430
  5. Zanarini MC, Frankenburg FR. The essential nature of borderline psychopathology. J Pers Disord. 2007 Oct; 21(5):518-35.
    View in: PubMed
    Score: 0.411
  6. Frankenburg FR, Zanarini MC. Personality disorders and medical comorbidity. Curr Opin Psychiatry. 2006 Jul; 19(4):428-31.
    View in: PubMed
    Score: 0.377
  7. Frankenburg FR, Zanarini MC. Obesity and obesity-related illnesses in borderline patients. J Pers Disord. 2006 Feb; 20(1):71-80.
    View in: PubMed
    Score: 0.366
  8. Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry. 2004 Dec; 65(12):1660-5.
    View in: PubMed
    Score: 0.338
  9. Zanarini MC, Frankenburg FR. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003 Jan; 160(1):167-9.
    View in: PubMed
    Score: 0.296
  10. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry. 2002 May; 63(5):442-6.
    View in: PubMed
    Score: 0.282
  11. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2001 Nov; 62(11):849-54.
    View in: PubMed
    Score: 0.273
  12. Zanarini MC, Frankenburg FR. Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Compr Psychiatry. 2001 Sep-Oct; 42(5):369-74.
    View in: PubMed
    Score: 0.270
  13. Shah R, Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Levels of Depersonalization and Derealization Reported by Recovered and Non-recovered Borderline Patients Over 20 Years of Prospective Follow-up. J Trauma Dissociation. 2020 May-Jun; 21(3):337-348.
    View in: PubMed
    Score: 0.241
  14. Ridolfi ME, Temer CM, Fraser EK, Frankenburg FR, Zanarini MC. Perceived Caretaker Malevolence During Childhood Reported by Borderline Patients and Personality-Disordered Comparison Subjects: Description and Prediction. J Pers Disord. 2019 Oct 14; 1-9.
    View in: PubMed
    Score: 0.237
  15. Zanarini MC, Hörz-Sagstetter S, Temes CM, Frankenburg FR, Hein KE, Reich DB, Fitzmaurice GM. The 24-year course of major depression in patients with borderline personality disorder and personality-disordered comparison subjects. J Affect Disord. 2019 11 01; 258:109-114.
    View in: PubMed
    Score: 0.233
  16. Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Deaths by Suicide and Other Causes Among Patients With Borderline Personality Disorder and Personality-Disordered Comparison Subjects Over 24 Years of Prospective Follow-Up. J Clin Psychiatry. 2019 01 22; 80(1).
    View in: PubMed
    Score: 0.225
  17. Zanarini MC, Temes CM, Frankenburg FR, Reich DB, Fitzmaurice GM. Levels of Acceptance and Forgiveness Reported by Patients With BPD and Personality-Disordered Comparison Subjects Over 20 Years of Prospective Follow-Up. J Pers Disord. 2020 Apr; 34(2):262-272.
    View in: PubMed
    Score: 0.225
  18. Gad MA, Pucker HE, Hein KE, Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Facets of identity disturbance reported by patients with borderline personality disorder and personality-disordered comparison subjects over 20 years of prospective follow-up. Psychiatry Res. 2019 01; 271:76-82.
    View in: PubMed
    Score: 0.222
  19. Borkum DB, Frankenburg FR, Fitzmaurice GM, Athanasiadi A, Temes CM, Reich B, Zanarini MC. Predictors of Slower Time-to-Cessation of Individual Therapy for Borderline Patients Over 16 Years of Prospective Follow-Up. J Pers Disord. 2019 02; 33(1):135-144.
    View in: PubMed
    Score: 0.212
  20. Zanarini MC, Temes CM, Frankenburg FR, Reich DB, Fitzmaurice GM. Description and prediction of time-to-attainment of excellent recovery for borderline patients followed prospectively for 20 years. Psychiatry Res. 2018 04; 262:40-45.
    View in: PubMed
    Score: 0.211
  21. Zanarini MC, Williams AA, Lewis RE, Reich RB, Vera SC, Marino MF, Levin A, Yong L, Frankenburg FR. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry. 1997 Aug; 154(8):1101-6.
    View in: PubMed
    Score: 0.203
  22. Zanarini MC, Temes CM, Ivey AM, Cohn DM, Conkey LC, Frankenburg FR, Fitzmaurice GM. The 10-year course of adult aggression toward others in patients with borderline personality disorder and axis II comparison subjects. Psychiatry Res. 2017 06; 252:134-138.
    View in: PubMed
    Score: 0.197
  23. Zanarini MC, Frankenburg FR. Pathways to the development of borderline personality disorder. J Pers Disord. 1997; 11(1):93-104.
    View in: PubMed
    Score: 0.195
  24. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice GM. Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up. Am J Psychiatry. 2016 07 01; 173(7):688-94.
    View in: PubMed
    Score: 0.183
  25. Karan E, Niesten IJ, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Prevalence and course of sexual relationship difficulties in recovered and non-recovered patients with borderline personality disorder over 16?years of prospective follow-up. Personal Ment Health. 2016 08; 10(3):232-43.
    View in: PubMed
    Score: 0.183
  26. Niesten IJ, Karan E, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Description and prediction of the income status of borderline patients over 10???years of prospective follow-up. Personal Ment Health. 2016 11; 10(4):285-292.
    View in: PubMed
    Score: 0.183
  27. Zanarini MC, Weingeroff JL, Frankenburg FR, Fitzmaurice GM. Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder. Personal Ment Health. 2015 Nov; 9(4):243-9.
    View in: PubMed
    Score: 0.176
  28. Zanarini MC, Frankenburg FR, Bradford Reich D, Harned AL, Fitzmaurice GM. Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up. J Clin Psychopharmacol. 2015 Feb; 35(1):63-7.
    View in: PubMed
    Score: 0.171
  29. Zanarini MC, Frankenburg FR, Fitzmaurice GM. Severity of anxiety symptoms reported by borderline patients and Axis II comparison subjects: description and prediction over 16 years of prospective follow-up. J Pers Disord. 2014 Dec; 28(6):767-77.
    View in: PubMed
    Score: 0.169
  30. Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM. Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study. Psychiatr Serv. 2015 Jan 01; 66(1):15-20.
    View in: PubMed
    Score: 0.168
  31. Frankenburg FR, Zanarini MC. Uses of clozapine in nonschizophrenic patients. Harv Rev Psychiatry. 1994 Sep-Oct; 2(3):142-50.
    View in: PubMed
    Score: 0.166
  32. Martinho E, Fitzmaurice GM, Frankenburg FR, Zanarini MC. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up. J Clin Psychopharmacol. 2014 Aug; 34(4):499-503.
    View in: PubMed
    Score: 0.165
  33. Biskin RS, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Pain in patients with borderline personality disorder. Personal Ment Health. 2014 Aug; 8(3):218-27.
    View in: PubMed
    Score: 0.164
  34. Zanarini MC, Frankenburg FR, Reich DB, Wedig MM, Conkey LC, Fitzmaurice GM. The course of marriage/sustained cohabitation and parenthood among borderline patients followed prospectively for 16 years. J Pers Disord. 2015 Feb; 29(1):62-70.
    View in: PubMed
    Score: 0.164
  35. Karan E, Niesten IJ, Frankenburg FR, Fitzmaurice GM, Zanarini MC. The 16-year course of shame and its risk factors in patients with borderline personality disorder. Personal Ment Health. 2014 Aug; 8(3):169-77.
    View in: PubMed
    Score: 0.160
  36. Zanarini MC, Frankenburg FR, Reich DB, Wedig MM, Conkey LC, Fitzmaurice GM. Prediction of time-to-attainment of recovery for borderline patients followed prospectively for 16 years. Acta Psychiatr Scand. 2014 Sep; 130(3):205-13.
    View in: PubMed
    Score: 0.160
  37. Zanarini MC, Frankenburg FR. Emotional hypochondriasis, hyperbole, and the borderline patient. J Psychother Pract Res. 1994; 3(1):25-36.
    View in: PubMed
    Score: 0.158
  38. Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry. 1993 Nov-Dec; 34(6):402-5.
    View in: PubMed
    Score: 0.157
  39. Niesten IJ, Karan E, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Prevalence and risk factors for irritable bowel syndrome in recovered and non-recovered borderline patients over 10?years of prospective follow-up. Personal Ment Health. 2014 Feb; 8(1):14-23.
    View in: PubMed
    Score: 0.156
  40. Plante DT, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Relationship between maladaptive cognitions about sleep and recovery in patients with borderline personality disorder. Psychiatry Res. 2013 Dec 30; 210(3):975-9.
    View in: PubMed
    Score: 0.155
  41. Keuroghlian AS, Frankenburg FR, Zanarini MC. The relationship of chronic medical illnesses, poor health-related lifestyle choices, and health care utilization to recovery status in borderline patients over a decade of prospective follow-up. J Psychiatr Res. 2013 Oct; 47(10):1499-506.
    View in: PubMed
    Score: 0.153
  42. Zanarini MC, Laudate CS, Frankenburg FR, Wedig MM, Fitzmaurice G. Reasons for self-mutilation reported by borderline patients over 16 years of prospective follow-up. J Pers Disord. 2013 Dec; 27(6):783-94.
    View in: PubMed
    Score: 0.153
  43. Wedig MM, Frankenburg FR, Bradford Reich D, Fitzmaurice G, Zanarini MC. Predictors of suicide threats in patients with borderline personality disorder over 16 years of prospective follow-up. Psychiatry Res. 2013 Aug 15; 208(3):252-6.
    View in: PubMed
    Score: 0.152
  44. Zanarini MC, Frankenburg FR, Wedig MM, Fitzmaurice GM. Cognitive experiences reported by patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry. 2013 Jun; 170(6):671-9.
    View in: PubMed
    Score: 0.152
  45. Plante DT, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Relationship between sleep disturbance and recovery in patients with borderline personality disorder. J Psychosom Res. 2013 Apr; 74(4):278-82.
    View in: PubMed
    Score: 0.149
  46. Zanarini MC, Frankenburg FR, Fitzmaurice G. Defense mechanisms reported by patients with borderline personality disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of recovery. Am J Psychiatry. 2013 Jan; 170(1):111-20.
    View in: PubMed
    Score: 0.148
  47. Silverman MH, Frankenburg FR, Reich DB, Fitzmaurice G, Zanarini MC. The course of anxiety disorders other than PTSD in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. J Pers Disord. 2012 Oct; 26(5):804-14.
    View in: PubMed
    Score: 0.145
  48. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry. 2012 May; 169(5):476-83.
    View in: PubMed
    Score: 0.141
  49. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and Stability of Sustained Symptomatic Remission and Recovery Among Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 16-Year Prospective Follow-Up Study. Am J Psychiatry. 2012 May 1; 169(5):476-83.
    View in: PubMed
    Score: 0.141
  50. McGowan A, King H, Frankenburg FR, Fitzmaurice G, Zanarini MC. The course of adult experiences of abuse in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. J Pers Disord. 2012 Apr; 26(2):192-202.
    View in: PubMed
    Score: 0.140
  51. Wedig MM, Silverman MH, Frankenburg FR, Reich DB, Fitzmaurice G, Zanarini MC. Predictors of suicide attempts in patients with borderline personality disorder over 16 years of prospective follow-up. Psychol Med. 2012 Nov; 42(11):2395-404.
    View in: PubMed
    Score: 0.140
  52. Zanarini MC, Hörz S, Frankenburg FR, Weingeroff J, Reich DB, Fitzmaurice G. The 10-year course of PTSD in borderline patients and axis II comparison subjects. Acta Psychiatr Scand. 2011 Nov; 124(5):349-56.
    View in: PubMed
    Score: 0.132
  53. Zanarini MC, Laudate CS, Frankenburg FR, Reich DB, Fitzmaurice G. Predictors of self-mutilation in patients with borderline personality disorder: A 10-year follow-up study. J Psychiatr Res. 2011 Jun; 45(6):823-8.
    View in: PubMed
    Score: 0.128
  54. Zanarini MC, Frankenburg FR, Frankenbur FR, Weingeroff JL, Reich DB, Fitzmaurice GM, Weiss RD. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction. 2011 Feb; 106(2):342-8.
    View in: PubMed
    Score: 0.128
  55. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry. 2010 Jun; 167(6):663-7.
    View in: PubMed
    Score: 0.122
  56. Zanarini MC, Reichman CA, Frankenburg FR, Reich DB, Fitzmaurice G. The course of eating disorders in patients with borderline personality disorder: a 10-year follow-up study. Int J Eat Disord. 2010 Apr; 43(3):226-32.
    View in: PubMed
    Score: 0.122
  57. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. The 10-year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects. Acta Psychiatr Scand. 2010 Aug; 122(2):103-9.
    View in: PubMed
    Score: 0.121
  58. Zanarini MC, Gunderson JG, Frankenburg FR. Cognitive features of borderline personality disorder. Am J Psychiatry. 1990 Jan; 147(1):57-63.
    View in: PubMed
    Score: 0.120
  59. Zanarini MC, Jacoby RJ, Frankenburg FR, Reich DB, Fitzmaurice G. The 10-year course of social security disability income reported by patients with borderline personality disorder and axis II comparison subjects. J Pers Disord. 2009 Aug; 23(4):346-56.
    View in: PubMed
    Score: 0.117
  60. Zanarini MC, Barison LK, Frankenburg FR, Reich DB, Hudson JI. Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disorders. J Pers Disord. 2009 Aug; 23(4):357-69.
    View in: PubMed
    Score: 0.117
  61. Zanarini MC, Gunderson JG, Frankenburg FR. Axis I phenomenology of borderline personality disorder. Compr Psychiatry. 1989 Mar-Apr; 30(2):149-56.
    View in: PubMed
    Score: 0.113
  62. Zanarini MC, Gunderson JG, Marino MF, Schwartz EO, Frankenburg FR. Childhood experiences of borderline patients. Compr Psychiatry. 1989 Jan-Feb; 30(1):18-25.
    View in: PubMed
    Score: 0.112
  63. Zanarini MC, Frankenburg FR, Jager-Hyman S, Reich DB, Fitzmaurice G. The course of dissociation for patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. Acta Psychiatr Scand. 2008 Oct; 118(4):291-6.
    View in: PubMed
    Score: 0.109
  64. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G, Weinberg I, Gunderson JG. The 10-year course of physically self-destructive acts reported by borderline patients and axis II comparison subjects. Acta Psychiatr Scand. 2008 Mar; 117(3):177-84.
    View in: PubMed
    Score: 0.105
  65. Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry. 2007 Jun; 164(6):929-35.
    View in: PubMed
    Score: 0.100
  66. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry. 2006 May; 163(5):827-32.
    View in: PubMed
    Score: 0.093
  67. Zanarini MC, Frankenburg FR, Ridolfi ME, Jager-Hyman S, Hennen J, Gunderson JG. Reported childhood onset of self-mutilation among borderline patients. J Pers Disord. 2006 Feb; 20(1):9-15.
    View in: PubMed
    Score: 0.092
  68. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord. 2005 Oct; 19(5):505-23.
    View in: PubMed
    Score: 0.089
  69. Zanarini MC, Frankenburg FR, Reich DB, Hennen J, Silk KR. Adult experiences of abuse reported by borderline patients and Axis II comparison subjects over six years of prospective follow-up. J Nerv Ment Dis. 2005 Jun; 193(6):412-6.
    View in: PubMed
    Score: 0.087
  70. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord. 2005 Feb; 19(1):19-29.
    View in: PubMed
    Score: 0.085
  71. Zanarini MC, Frankenburg FR, Vujanovic AA, Hennen J, Reich DB, Silk KR. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission. Acta Psychiatr Scand. 2004 Dec; 110(6):416-20.
    View in: PubMed
    Score: 0.084
  72. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004 Nov; 161(11):2108-14.
    View in: PubMed
    Score: 0.084
  73. Zanarini MC, Frankenburg FR, Yong L, Raviola G, Bradford Reich D, Hennen J, Hudson JI, Gunderson JG. Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. J Pers Disord. 2004 Oct; 18(5):439-47.
    View in: PubMed
    Score: 0.083
  74. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004 Jul; 65(7):903-7.
    View in: PubMed
    Score: 0.082
  75. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry. 2004 Jan; 65(1):28-36.
    View in: PubMed
    Score: 0.079
  76. Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003 Dec; 17(6):568-73.
    View in: PubMed
    Score: 0.079
  77. Zanarini MC, Parachini EA, Frankenburg FR, Holman JB, Hennen J, Reich DB, Silk KR. Sexual relationship difficulties among borderline patients and axis II comparison subjects. J Nerv Ment Dis. 2003 Jul; 191(7):479-82.
    View in: PubMed
    Score: 0.076
  78. Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003 Jun; 17(3):233-42.
    View in: PubMed
    Score: 0.076
  79. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry. 2003 Feb; 160(2):274-83.
    View in: PubMed
    Score: 0.074
  80. Zanarini MC, Yong L, Frankenburg FR, Hennen J, Reich DB, Marino MF, Vujanovic AA. Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients. J Nerv Ment Dis. 2002 Jun; 190(6):381-7.
    View in: PubMed
    Score: 0.071
  81. Zanarini MC, Frankenburg FR, Vujanovic AA. Inter-rater and test-retest reliability of the Revised Diagnostic Interview for Borderlines. J Pers Disord. 2002 Jun; 16(3):270-6.
    View in: PubMed
    Score: 0.071
  82. Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J. Treatment histories of borderline inpatients. Compr Psychiatry. 2001 Mar-Apr; 42(2):144-50.
    View in: PubMed
    Score: 0.065
  83. Zanarini MC, Ruser T, Frankenburg FR, Hennen J. The dissociative experiences of borderline patients. Compr Psychiatry. 2000 May-Jun; 41(3):223-7.
    View in: PubMed
    Score: 0.061
  84. Zanarini MC, Frankenburg FR, Reich DB, Marino MF, Lewis RE, Williams AA, Khera GS. Biparental failure in the childhood experiences of borderline patients. J Pers Disord. 2000; 14(3):264-73.
    View in: PubMed
    Score: 0.060
  85. Zanarini MC, Ruser TF, Frankenburg FR, Hennen J, Gunderson JG. Risk factors associated with the dissociative experiences of borderline patients. J Nerv Ment Dis. 2000 Jan; 188(1):26-30.
    View in: PubMed
    Score: 0.060
  86. Zanarini MC, Frankenburg FR, Reich DB, Marino MF, Haynes MC, Gunderson JG. Violence in the lives of adult borderline patients. J Nerv Ment Dis. 1999 Feb; 187(2):65-71.
    View in: PubMed
    Score: 0.056
  87. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998 Dec; 155(12):1733-9.
    View in: PubMed
    Score: 0.056
  88. Zanarini MC, Frankenburg FR, DeLuca CJ, Hennen J, Khera GS, Gunderson JG. The pain of being borderline: dysphoric states specific to borderline personality disorder. Harv Rev Psychiatry. 1998 Nov-Dec; 6(4):201-7.
    View in: PubMed
    Score: 0.055
  89. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis II comorbidity of borderline personality disorder. Compr Psychiatry. 1998 Sep-Oct; 39(5):296-302.
    View in: PubMed
    Score: 0.055
  90. Frankenburg FR, Zanarini MC, Kando J, Centorrino F. Clozapine and body mass change. Biol Psychiatry. 1998 Apr 01; 43(7):520-4.
    View in: PubMed
    Score: 0.053
  91. Nitenson NC, Kando JC, Frankenburg FR, Zanarini MC. Fever associated with clozapine administration. Am J Psychiatry. 1995 Jul; 152(7):1102.
    View in: PubMed
    Score: 0.044
  92. Zanarini MC, Gunderson JG, Frankenburg FR, Chauncey DL, Glutting JH. The face validity of the DSM-III and DSM-III-R criteria sets for borderline personality disorder. Am J Psychiatry. 1991 Jul; 148(7):870-4.
    View in: PubMed
    Score: 0.033
  93. Hörz S, Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Ten-year use of mental health services by patients with borderline personality disorder and with other axis II disorders. Psychiatr Serv. 2010 Jun; 61(6):612-6.
    View in: PubMed
    Score: 0.031
  94. Choi-Kain LW, Zanarini MC, Frankenburg FR, Fitzmaurice GM, Reich DB. A longitudinal study of the 10-year course of interpersonal features in borderline personality disorder. J Pers Disord. 2010 Jun; 24(3):365-76.
    View in: PubMed
    Score: 0.031
  95. Zanarini MC, Gunderson JG, Frankenburg FR, Chauncey DL. Discriminating borderline personality disorder from other axis II disorders. Am J Psychiatry. 1990 Feb; 147(2):161-7.
    View in: PubMed
    Score: 0.030
  96. Zanarini MC, Frankenburg FR, Pope HG, Hudson JI, Yurgelun-Todd D, Cicchetti CJ. Axis II comorbidity of normal-weight bulimia. Compr Psychiatry. 1990 Jan-Feb; 31(1):20-4.
    View in: PubMed
    Score: 0.030
  97. Plante DT, Zanarini MC, Frankenburg FR, Fitzmaurice GM. Sedative-hypnotic use in patients with borderline personality disorder and axis II comparison subjects. J Pers Disord. 2009 Dec; 23(6):563-71.
    View in: PubMed
    Score: 0.030
  98. Zanarini MC, Frankenburg FR, Gunderson JG. Pharmacotherapy of borderline outpatients. Compr Psychiatry. 1988 Jul-Aug; 29(4):372-8.
    View in: PubMed
    Score: 0.027
  99. Zanarini MC, Frankenburg FR, Chauncey DL, Gunderson JG. The diagnostic Interview for Personality Disorders: interrater and test-retest reliability. Compr Psychiatry. 1987 Nov-Dec; 28(6):467-80.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.